Clinical Trial Detail

NCT ID NCT02876224
Title Study of Cobimetinib in Combination With Atezolizumab and Bevacizumab in Participants With Gastrointestinal and Other Tumors
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors Hoffmann-La Roche
Indications

colorectal adenocarcinoma

Therapies

Atezolizumab + Bevacizumab + Cobimetinib

Age Groups: senior adult

No variant requirements are available.